(Q39677855)

13 September 2017

1 reference

title

Antioxidant therapy in Parkinson's disease (English)

1 reference

13 September 2017

1 reference

Grimes JD

1

1 reference

13 September 2017

Hassan MN

series ordinal

2

1 reference

13 September 2017

Thakar J

series ordinal

3

1 reference

13 September 2017

publication date

1 August 1987

1 reference

Canadian Journal of Neurological Sciences

13 September 2017

published in

1 reference

13 September 2017

volume

14

1 reference

13 September 2017

issue

3 Suppl

1 reference

13 September 2017

page(s)

483-487

1 reference

Pargyline and deprenyl prevent the neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in monkeys.

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Electrophysiologic features of abetalipoproteinemia: functional consequences of vitamin E deficiency.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Membrane effects of vitamin E deficiency: bioenergetic and surface charge density studies of skeletal muscle and liver mitochondria

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Motorneurone disease on Guam: possible role of a food neurotoxin

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Ecogenetics of Parkinson's disease: 4-hydroxylation of debrisoquine

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Does an endogenous methylpyridinium analogue cause Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Locus ceruleus lesions and eosinophilic inclusions in MPTP-treated monkeys.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Age-dependent effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Influence of oxygen tension, pro-oxidants and antioxidants on the formation of lipid peroxidation products (lipofuscin) in individual cultivated human glial cells

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year period.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Ascorbic acid reduces the dopamine depletion induced by MPTP.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Depletion of glutathione in brainstem of mice caused by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine is prevented by antioxidant pretreatment.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metals

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Inhibition of Biogenic Amine Uptake by Hydrogen Peroxide: A Mechanism for Toxic Effects of 6-Hydroxydopamine

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Increased life expectancy resulting from addition of L-deprenyl to Madopar treatment in Parkinson's disease: a longterm study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Antioxidants fail to inhibit depletion of striatal dopamine by MPTP.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Partial protection from the dopaminergic neurotoxin N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by four different antioxidants in the mouse.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Lipid peroxides in brain during aging and vitamin E deficiency: Possible relations to changes in neurotransmitter indices

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Progressive neuropathologic lesions in vitamin E-deficient rhesus monkeys

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Deposits of fluorescent acid-fast products in the nervous system and skeletal muscles of adult rats with chronic vitamin-E deficiency

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Cigarette smoking and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Parkinson's disease: a disorder due to nigral glutathione deficiency?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Brain Peroxidase and Catalase in Parkinson Disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

The clinical syndrome of striatal dopamine deficiency. Parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Initiation of levodopa therapy in parkinsonian patients should be delayed until the advanced stages of the disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Permanent human parkinsonism due to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): seven cases

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

MPTP-like molecules and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Deprenyl administration in man: A selective monoamine oxidase B inhibitor without the ?cheese effect?

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Production in nature of compound resembling methylphenyltetrahydropyridine, a possible cause of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

The possible relation of glutathione, melanin and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) to Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Aetiology of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

VITAMIN E AND NEUROLOGICAL FUNCTION

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Free radicals, lipid peroxidation, and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Protection against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity by the antioxidant ascorbic acid.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

The spectrum of neurologic disorder from vitamin E deficiency

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Aging and Extrapyramidal Function

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

Etiology of Parkinson's disease: A research strategy

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

MPTP: a neurotoxin relevant to the pathophysiology of Parkinson's disease. The 1985 George C. Cotzias lecture

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100037951

7 January 2021

10.1017/S0317167100037951

Identifiers

DOI

0 references

1 reference